Borasio GD, Robberecht W, Leigh PN, et al
Lipid panel: clinical trials have documented triglyceride reductions on tesamorelin
Based on the published literature for its individual components, GLOW is relevant to research involving tissue repair, tendon and ligament biology, connective tissue remodelling, angiogenesis, musculoskeletal research, wound healing and extracellular matrix regulation
Reduced incretin effect in type 2 (non-insulin-dependent) diabetes
Healthcare System Navigation Canadian healthcare providers generally cannot prescribe or officially recommend BPC-157 given its unapproved status
We are working with researchers to address this problem but it is still early days yet